Inflammation markers help predict breast cancer survival

05/27/2009 | Boston Globe (tiered subscription model), The

U.S. researchers found breast cancer patients with high levels of C-reactive protein and serum amyloid A, both markers for inflammation, were two to three times more likely to die early or have a recurrence of the disease. Testing for these markers could help determine a woman's prognosis, they said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN